(704) 290-4587

EFC16750: Study to assess the efficacy, stafety, and tolerability of sar440340/
itepekimab in chronic obstructive pulmonary disease(COPD) (AERIFY-1)

Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD.

Carolina Clinical Research is currently seeking study participants 40 to 85 years of age with a current COPD diagnosis of at least one year, with a smoking history of greater than or equal to 10 years, but who are not currently smoking. 

This study is currently sponsored by Sanofi, in collaboration with Regeneron Pharmaceuticals. 

Click Here to read the full trial information 

 Click here to request participant information